PURPOSE: To determine the on-eye effect of spherical and toric contact lens design on higher-order aberrations (HOA). METHODS:Thirty eyes (15 subjects) entered a masked, randomized, cross-over study. Each eye was fitted with the spherical and toric lens of the following brands in random order: Acuvue Advance, Biomedics 55, Frequency 55, and SofLens 66. HOAs were measured using the Zywave II Aberrometer over a 6-mm aperture up to fifth order. A linear model accounting for the fixed effect of lens type and random effects of subject and eye was created. Paired t-tests were completed between lens brands within the spherical and toric lenses and between the spherical and toric lens within each brand. Best-corrected visual acuity (VA) was measured and compared. RESULTS: No clinically meaningful differences in total HOAs were found between brands or between the spherical and toric lens within a brand. Positive spherical aberration (SA) was reduced by all spherical and toric lenses compared to wearing no lens by 0.07 to 0.23 microm (p < 0.0001). Frequency toric induced the greatest change in SA. The thin-zone design lens (Acuvue Advance for Astigmatism) had a statistically different amount of vertical coma (-0.04 microm) than the three prism-balast toric lenses (0.11 to 0.23 microm; p < 0.0001). SofLens toric had the greatest amount of vertical coma, but better VA than Acuvue Advance for Astigmatism and Frequency toric. With the exception of Acuvue Advance for Astigmatism, toric lenses had greater absolute magnitude of vertical coma than their sphere counterparts (all p < 0.002). No other significant HOA differences were observed. CONCLUSIONS: Toric contact lenses with prism-ballast designs demonstrated more vertical coma, but better VA. Positive SA was reduced by spherical and toric contact lenses. The visual quality effect of lens design and material on induced HOAs warrants further investigation.
RCT Entities:
PURPOSE: To determine the on-eye effect of spherical and toric contact lens design on higher-order aberrations (HOA). METHODS: Thirty eyes (15 subjects) entered a masked, randomized, cross-over study. Each eye was fitted with the spherical and toric lens of the following brands in random order: Acuvue Advance, Biomedics 55, Frequency 55, and SofLens 66. HOAs were measured using the Zywave II Aberrometer over a 6-mm aperture up to fifth order. A linear model accounting for the fixed effect of lens type and random effects of subject and eye was created. Paired t-tests were completed between lens brands within the spherical and toric lenses and between the spherical and toric lens within each brand. Best-corrected visual acuity (VA) was measured and compared. RESULTS: No clinically meaningful differences in total HOAs were found between brands or between the spherical and toric lens within a brand. Positive spherical aberration (SA) was reduced by all spherical and toric lenses compared to wearing no lens by 0.07 to 0.23 microm (p < 0.0001). Frequency toric induced the greatest change in SA. The thin-zone design lens (Acuvue Advance for Astigmatism) had a statistically different amount of vertical coma (-0.04 microm) than the three prism-balast toric lenses (0.11 to 0.23 microm; p < 0.0001). SofLens toric had the greatest amount of vertical coma, but better VA than Acuvue Advance for Astigmatism and Frequency toric. With the exception of Acuvue Advance for Astigmatism, toric lenses had greater absolute magnitude of vertical coma than their sphere counterparts (all p < 0.002). No other significant HOA differences were observed. CONCLUSIONS: Toric contact lenses with prism-ballast designs demonstrated more vertical coma, but better VA. Positive SA was reduced by spherical and toric contact lenses. The visual quality effect of lens design and material on induced HOAs warrants further investigation.
Authors: Konrad Pesudovs; Jason D Marsack; William J Donnelly; Larry N Thibos; Raymond A Applegate Journal: J Refract Surg Date: 2004 Sep-Oct Impact factor: 3.573
Authors: Colm McAlinden; Jonathan E Moore; Victoria E McGilligan; Tara C B Moore Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-08-06 Impact factor: 3.117
Authors: Amir Asharlous; Ebrahim Jafarzadehpur; Ali Mirzajani; Mehdi Khabazkhoob; Samira Heydarian; Ali Taghipour Journal: J Curr Ophthalmol Date: 2016-07-25